Previous studies indicate that HDAC inhibitors sensitize melanoma cells to immunotherapy44 possibly due to its endoplasmic reticulum stress and autophagy provoking activity45, two processes crucial in eliciting immunogenic cancer cell death46. This evidence concerns the gene HDAC9 and melanoma.